--- title: "04:11 ET DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/268043785.md" description: "DJS Law Group announces a class action lawsuit against DexCom, Inc. for securities law violations, alleging false and misleading statements related to unauthorized product changes affecting reliability and health risks. Shareholders who purchased DXCM shares between July 26, 2024, and September 17, 2025, are encouraged to contact the firm for potential lead plaintiff appointments. The deadline for participation is December 26, 2025." datetime: "2025-12-01T09:12:34.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/268043785.md) - [en](https://longbridge.com/en/news/268043785.md) - [zh-HK](https://longbridge.com/zh-HK/news/268043785.md) --- > 支持的语言: [English](https://longbridge.com/en/news/268043785.md) | [繁體中文](https://longbridge.com/zh-HK/news/268043785.md) # 04:11 ET DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM , /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom " or "the Company") (NASDAQ: DXCM ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. **CLASS PERIOD:** July 26, 2024 to September 17, 2025 **DEADLINE:** December 26, 2025 **CASE DETAILS:** According to the Complaint, the Company made false and misleading statements to the market. DexCom made certain product changes without FDA authorization. The Company's product changes lowered their reliability, creating health risks for users. Based on these facts, DexCom's public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate . **NEXT STEPS FOR SHAREHOLDERS** : Once you register as a shareholder who purchased shares during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case. **WHY DJS LAW GROUP?** DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results. Join the case to recover your losses. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. **CONTACT:** David J. Schwartz DJS Law Group 274 White Plains Road, Suite 1 Eastchester, NY 10709 Phone: 914-206-9742 Email: \[email protected\] SOURCE DJS Law Group LLP ### 相关股票 - [DexCom (DXCM.US)](https://longbridge.com/zh-CN/quote/DXCM.US.md) ## 相关资讯与研究 - [Class Action Filing Announced by Pomerantz LLP Against DexCom, Inc. – DXCM](https://longbridge.com/zh-CN/news/270219532.md) - [Class Action Filed by Pomerantz LLP Against DexCom, Inc. – DXCM](https://longbridge.com/zh-CN/news/269926596.md) - [Class Action Now Underway by Pomerantz LLP Against DexCom, Inc. – DXCM](https://longbridge.com/zh-CN/news/269441379.md) - [Class Action Litigation Filed by Pomerantz LLP for Investors of DexCom, Inc. – DXCM](https://longbridge.com/zh-CN/news/269146697.md) - [Class Action by Pomerantz LLP Filed Against DexCom, Inc. – DXCM](https://longbridge.com/zh-CN/news/268944867.md)